Summary A host's ability to resist certain pathogens such as Leishmania major can depend upon the phenotype of T helper (Th) subset that develops. Different murine genetic backgrounds are known to significantly alter the direction of Th subset development, although the cellular basis of this influence is poorly understood. To examine the basis of this effect we used an in vitro od3-T cell receptor (TCR) transgenic system for analysis of Th phenotype development. To control for TCR. usage, we derived the DOl1.10 c~/3-TCR transgene in several genetic backgrounds. Our findings suggest that the effects of genetic background on Th phenotype development reside within the T cell, and not the antigen-presenting cell compartment. Transgenic T cells from both the B10.D2 and BALB/c backgrounds showed development toward either the Thl or Th2 phenotype under the strong directing influence of interleukin (IL) 12 and IL-4, respectively. However, when T cells were activated in vitro under neutral conditions in which exogenous cytokines were not added, B10.D2-derived T cells acquired a significantly stronger Thl phenotype than T cells from the BALB/c background, correspondent with in vivo Th responses to Leishmania in these strains. Importantly, these cytokine differences resulted in distinct functional properties, because B10.D2-but not BALB/c-derived T cells could induce macrophage production of nitric oxide, an important antimicrobial factor. Thus, the genetically determined default Th phenotype development observed in vitro may correspond to in vivo Th subset responses for pathogens such as Leishmania which do not initiate strong Th phenotype-directing signals.
S
ubsets of CD4 § Th cells regulate the effector mechamsms of the immune response through the production of distinct patterns of cytokines (1) (2) (3) . The subset of T cells termed Thl cells, which produce IL-2, IFN-% and lymphotoxin, are important for immunity against viral and intracellular pathogens, such as Leishmania major (1) (2) (3) (4) (5) . In contrast, Th2 cells produce IL-4, IL-5, IL-10, and IL-13, which contribute either to the direct enhancement of humoralmediated immunity or to the suppression of cell-mediated immunity (1) (2) (3) (4) (5) . Thus, by directly regulating the effector mechanisms that evolve during an immune response-to pathogen, these distinct Th subsets can have a profound impact on the host's resistance or susceptibility to distinct pathogens (4, 5) .
One of the best characterized examples of the association between the Th subset of the immune response and the host's resistance to a pathogen is routine experimental Leishmaniasis (6) (7) (8) (9) . In this model, susceptibility is associated with the development of a Th2-dominated immune response, whereas Thl-dominated responses resolve the infection. Susceptibility to Leishmania is not due to the absence of precursor cells of either Th subset, since several immunological manipulations can redirect the genetically determined Th subset development (10) (11) (12) (13) (14) (15) (16) (17) . Strikingly, such immunological manipulations must be carried out within the first week after infection (11, 18) . Thus, the period early after Leishmania infection appears critical for the establishment of either a curative Thl or an exacerbating Th2 response.
Many recent in vivo and in vitro studies have indicated that cytokines present during early T cell activation by antigen can profoundly influence the direction of Th phenotype development (11) (12) (13) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . It has been suggested that genetic differences in the regulation of these cytokine-mediated mechanisms may determine resistance or susceptibility to Le/shman/a (11) . However, a recent study by Reiner et al. (28) found little differences in the mR.NA levels of cytokines produced within the first 4 d during infection of genetically susceptible BALB/c or resistant C57BL/6 mice. In particular, the production of IL-4 and IL-12, which are the dominant inducers of Th2 and Thl development, respectively (10-12, 19, 20, 22-26) , was not significantly different during this critical early period of Th phenotype development. Whereas other candidate mechanisms have been recently proposed (29) , the genetic basis for susceptibility to L. major is largely still unresolved.
We have previously employed a murine a/~-TCR transgenic system to examine the regulation of Thl and Th2 phenotype development (22) . This in vitro TCR transgenic model allows manipulation and early examination of developmental events under well-defined conditions of APCs, cytokines, and exposure to pathogens. Using this system, we recently demonstrated that certain bacteria can elicit Thl responses by inducing macrophage production of IL-12 (24, 30, 31) . Thus, this TCR transgenic model might be useful for the study of the genetic basis of Leishmania susceptibility since we can easily manipulate the genetic background of either the APC or the responding T cell. By defining the cellular locus of the genetic susceptibility, we may facilitate definition of the molecular basis of this difference.
In this report, we find that L. major promastigotes have little effect on Th phenotype development in our transgenic model, regardless of the genetic background of the APC population (susceptible BALB/c, or resistant B10.D2 [6] ). Since Leishmania promastigotes fail to provide a strong stimulus for driving Th phenotype development to either extreme phenotype, genetic factors affecting the default development ofT cells may be responsible for strain differences in Th subset development during Leishmania infection. By breeding the DO-11.10 c~/~-TCR transgenes into the BALB/c and B10.D2 backgrounds, we have been able to directly compare the intrinsic tendencies of T cells from both genetic backgrounds to develop toward either Thl or Th2 cells. Our findings support a model in which the genetic susceptibility resides not in differential responses ofAPCs (macrophages) towards the Leishmania pathogen, but rather one in which the intrinsic capacity of T cells to develop towards the Th2 phenotype is amplified in the BALB/c background in the absence of pathogen-driven signals.
Materials and Methods
Animals. Mice transgenic for DOl1.10 cr (32) were selected by staining peripheral blood leukocytes with the anticlonotype mAb KJ1-26 (33) . TCR transgenics on the BALB/c background have been backcrossed for six to eight generations. TCR transgenics used in these experiments were bred to the B10.D2 or DBA/2J background for two to four or two to three generations. 4-6-wk-old female mice were purchased from Harlan Sprague Dawley (Indianapolis, IN) (BALB/c), or The Jackson Laboratory (Bar Harbor, ME) (BALB/cByJ, B10.D2/nSnJ, and DBA/2J).
Tissue Culture Media. Cultures were maintained in Iscove's modified Dulbecco's Eagle medium (GIBCO BRL, Gaithersburg, MD) supplemented with 10% FCS (Hyclone, Logan, UT), 2 mM L-glutamine, 0.1 mM sodium pyruvate, 0.1 mM MEM nonessential amino acids, 100 U/ml peninciUin, 100/zg/ml streptomycin (GIBCO BRL), and 50 #M 2-ME (Sigma Chemical Co., St. Louis, MO).
mAbs, Cytokines, and Reagents. The anti-IL-4 mAb 11Bll has been previously described (34 Flow Cytometric Purification of CD4 + T Cells. T cells were partially purified from spleens by complement lysis of CA4 (anti-class II) and 3.155 (anti-CD8) stained cells. After isolation on a density gradient (Histopaque-1119), T cells were stained with FITCconjugated anti-CD4 mAb, and PE-conjugated anti-MeM4 mAb (PharMingen), and sorted on a Flow cytometer (Epics 757; Coulter, Hialeah, FL) to achieve purities of ~98% MeM4 § CD4 § T cells. mAb staining had no effect on the function of T cells.
T Cell Culture. T cells (2.5 x 10S/well) were stimulated in 2-ml cultures in 24-well plates with 0.3/~M OVA peptide presented by irradiated BALB/c or B10.D2 splenocytes (2,600 tad, 5 x 106/well). Supernatants were collected at 48 h and cells were expanded threefold into fresh medium at 72 h. On day 7, the T cells were harvested, washed, counted, and restimulated at 2.5 x 10Vwell by 5 x 106 BALB/c splenocytes presenting 0.3 #M OVA peptide without added experimental conditions in order to determine the resulting Th cell phenotype. Supernatants were collected at 24 or 48 h and the eytokine profile of the T cell line was assayed by ELISA.
Experiments using sorted T cells were similar, except initial T cell numbers were lower (105). Thus, cultures were not expanded on day 3. Other aspects were identical, including restimulation conditions.
Nitrite Production Assay. 4-d thioglycolate-elicited peritoneal exudate cells (PECs) were adhered at 10S/well in 96-well plates for more than 4 h. After nonadherent cells were removed by washing (twice), T cells were added at indicated concentrations with 0.3 #M OVA peptide. Nitrite production was assessed at 36 h by reading the As4o of the mixture of 100/zl of cell-free supernatant with an equal volume of the Griess reagent (38) .
Cytokine Assays. Quantitation of IL-2, IL-4, and IFN-% was 714 Genetic Background Effects on Th Phenotype Development by capture ELISA as previously described (22) . II.,4 and IL-2 standards for ELISA were calibrated to cytokines purchased from Genzyme (Cambridge, MA). fiN-3' standards were the kind gift of Dr. R. D. Schreiber (Washington University School of Medicine).
Results and Discussion

APCs from B10.D2 and BALB/c Mice Do Not Differ in Their
Response to Leishmania major. Our previous studies using the ot/3-TCR transgenic system demonstrated that the induction of Thl development in OVA-specific T cells by Listeria monocytogenes is largely driven by macrophage production of IL-12 (24, 30, 39) . We therefore asked whether Thl responses to L. major in resistant strains might also be mediated by macrophage IL-12 production, and whether deficiencies in this pathway could explain Th2 responses to Leishmania in susceptible strains (10) . In these experiments, we used APCs from BALB/c or B10.D2 backgrounds for presentation of OVA to ot/~-TCR transgenic T ceils. These particular strains represent both Leishmania-resistant (B10.D2) and -susceptible (BALB/c) backgrounds which express I-A d, the restricting dement for the DOl1.10 ot/~-TCR. Addition of heat-killed Listeria induced Thl development when H-2 d splenic APCs from either BALB/c or B10.D2 mice were used for primary activation of transgenic T cells (Fig. 1 ). In contrast, live or heat-killed L. major promastigotes failed to induce Thl development regardless of the genetic background of the APCs used (Fig. 1) . Heat-killed L. major at high concentrations (5 x 106/well) slightly reduced the level of IFN-7 production seen upon in vitro restimulation at day 7, although these responses were similar for APCs of both strains (Fig. 1) .
The data for in vivo IL-12 expression during Leishmaniasis is controversial. Some have argued that IL-12 can be induced early during infection of some, but not all, resistant mouse strains, as reflected in the NK activity (29) . In contrast, our data are consistent with another report that IL-12 is not produced by macrophages in response to Leishmania promastigotes in vitro, and that IL-12 p40 mRNA is not upregulated early during infection in vivo (28) . Thus, the genetic basis of Thl development observed during in vivo Leishmania infection in these resistant strains may not result from the early enhanced production of IL-12 by macrophages. In the absence of the strong Thl-directing influences of IL-12 ( Fig. 1) , the factors most critical for determining genetic susceptibility to Leishmania would be those governing T cell development at neutral or default conditions.
One possibility was that the APCs from resistant strains might inherently favor Thl phenotype development. However, the intrinsic capacity ofB10.D2 APCs to direct Th phenotype development in vitro (Fig. 1) is not distinct from that of BALB/c APCs and thus cannot account for the enhanced Thl development in the B10.D2 strain observed during in vivo responses to Leishmania (6) .
Transgenic T Cells from BIO.D2 Mice Preferentially Develop under Neutral Conditions toward the Thl Phenotype in Comparison to BALB/c T Cells.
To directly test whether inherent T cell differences between these strains could account for varied Th phenotype development, we crossed the DOll.10 c~//~- TCR transgene into these genetic backgrounds to provide for uniform TCR use in naive CD4 § T cells. Because the DOl1.10 a/~-TCR is positively selected by I-A d, we specifically bred to Leishmania-susceptible (BALB/c) and -resistant (B10.D2) strains of the H-2 d haplotype. Since the H-2 d locus in the B10.D2 strain was derived from the DBA/2J strain, we also bred the TCR transgene into the DBA/2J strain as a control. Because positive selection is dependent not only on the particular MHC molecule, but also upon self peptides presented by the MHC, it was important to demonstrate that selection and peripheral maturation of transgenic T cells occurred similarly in each of these genetic backgrounds. Furthermore, because alterations in the level of surface markers can influence T cell responsiveness (40, 41), we also examined the levels of surface markers such as CD28 and CD4. We found that levels of KJ1-26 TCR clonotype, CD4, and CD8, are identical on T cells from ol/~-TCR transgenic mice bred to either the BALB/c (Fig. 2, a-c) , B10.D2 (Fig. 2, d-J derived from BALB/c mice reproducibly generated approximately two-to threefold less IFN-y and three-to fivefold greater levels of IL-4 than T cells derived from the B10.D2 background (Fig. 3 a, Table 1 ). These differences in cytokine profile were also evident in the tertiary stimulations ofT cells (data not shown), suggesting that these are stable properties of phenotype acquisition. However, the strain-dependent skewing of IL-4 and IFN-3~ production was not evident at 48 h during the primary stimulation ( Table 2 ), suggesting that freshly isolated B10.D2 T cells are not already of the :Fhl phenotype. Instead, these data suggest a predisposition for B10.D2 T cells to develop toward the Thl phenotype under neutral or default in vitro conditions, in comparison with BALB/c T cells. We also carried out an experiment in which T cells from both backgrounds were primed using APCs from each background. BALB/c-derived T cells, when primed as described in Table 1 with OVA and BALB/c splenocytes, produced 12.6 U/ml IFN-3' and 91 U/ml IL-4, and when primed with B10.D2 splenocytes, produced 9.4 U/ml IFN-'y and 90 U/ml IL-4, similar to results in Fig. 1 . In contrast, T cells from a third generation B10.D2 backcross, when primed with BALB/c splenocytes, produced 482 U/ml IFN-3' and <5 U/ml IL-4, and when primed with B10.D2 splenocytes, produced 666 U/ml IFN-3~ and <5 U/ml IL-4. These results confirm our earlier conclusion that the difference between these two backgrounds for Th phenotype resides within the T cell rather than within the APC (Fig. 1) .
Furthermore, these strain-dependent phenomena did not appear to be due to dramatic differences in primary T cell activation between BALB/c and B10.D2 T cells, or due to contaminating memory cells in the CD4 + T cell preparations. Experiments using populations of naive (Mel-14 ~i) CD4 § T cells showed similar results as experiments using unseparated CD4 + T cells (Table 1) . There was no difference in the levels of T cell proliferation between strains during the primary stimulation (assessed between 48 and 72 h, data not shown). However, recoveries from primary cultures of B10.D2 T cells were typically somewhat lower (mean 1.8-fold; range 1.1-3.7; n = 7) than recoveries from cultures of BALB/c T cells. Lastly, T cell production of IL-4 and IFN-y was similar for BALB/c-or B10.D2-derived T cells during the primary stimulation (Table 2) . It is unclear whether the differences in primary IL-2 or IL-4 levels (Table 2) could contribute toward the Th phenotype skewing observed, although it has been reported that these cytokines are important for the development of IL-4-producing cells (19) .
Whereas the DOl1.10 TCR has been maintained on the BALB/c background for approximately eight generations, the crosses to the B10. * Experiments were performed as described in Fig. 3 . Cytokine levels were assayed on 24-h supernatants. * T cells were FACS sorted for CD4 + Mel-14 hi expression. S 48-h supernatants.
serve significant effects of genetic background on Th phenotype development. First, the effect of the B10.D2 background on the enhanced Thl development seen in Fig. 3 was evident even in the initial (BALB/c x B10.D2)F1 cross (Table 1) .
Furthermore, additional backcrosses to the B10.D2 strain (up to four) did not produce qualitatively different results. This finding is consistent with the dominant or codominant resistance shown against Leiskmania in vivo (6, 42), although 
lO oJfl-TCR T Cells from Different Genetic Backgrounds during the Primary Stimulation
Cytokine production* Ratio of (U/ml _+ SE) BALB/c over B10.D2 * Average of at least five experiments as described in Fig. 3 .24-h cytokine levels for IFN-'y is extremely low (<4 U/ml) and for IL-4 is undetectable I IL-4 <0.8-1.5 U/ml), in contrast with 24-h supernatants after secondary stimulation. These levels are low and near the limit of detection (0.8-1.5 U/ml).
we cannot currently determine whether the effect results from a single or multiple genes. Second, the effect of the B10.D2 genetic background for enhancing Thl development was specific since this effect was not seen when the od~/-TCR transgene was bred for up to three generations to the DBA/2J genetic background. In fact, DBA/2J appeared to generate T cells under neutral conditions with an even greater Th2-like phenotype than the BALB/c background (Fig. 3 b) . Thus, even though B10.D2 and DBA/2J share the H-2 d MHC locus, the influence on Th phenotype development clearly segregated from the MHC. Similarly, resistance to Leishmania is not MHC dependent (6) . Third, we have examined cytokine production of nontransgenic T cells purified from BALB/c or B10.D2 mice using Con A as a polyclonal activator. Consistent with our data using TCR transgenic mice, T cells from genetically pure B10.D2 mice similarly produced more IFN-7 and less IL-4 than T cells from BALB/c mice after restimulation (data not shown).
The differences in default Th development observed for T cells derived from BALB/c or B10.D2 mice did not, however, represent a general defect in either Thl or Th2 development in these strains. T cells derived from either background developed into strong Thl cells when IL-4 was neutralized and IL-12 was added in primary cultures (Fig. 4) . Furthermore, the addition of IL-4 in primary cultures greatly inhibited IFN-3' production and enhanced IL-4 production during restimulation ofT cells from both BALB/c and B10.D2 strains. Thus, the previously described IL-12/IL-4 regulation of Thl and Th2 phenotype appeared to operate similarly in both genetic backgrounds. Once again, a significant difference in Th phenotype development was observed between these two genetic backgrounds when T cells are activated under neutral conditions (Fig. 4) .
BIO.D2 but Not BALB/c T Cells Developing under Neutral Conditions Are Capable of Inducing Nitric Oxide
We have consistently observed two-to threefold differences in IL-4 and IFN-y production between T cells derived from BALB/c or B10.D2 mice (Table 1) . However, the levels of cytokines produced under the default developmental pathway are low in comparison with T cells driven toward the Thl or Th2 phenotype with exogenous cytokines (Fig. 4) . It was therefore important to determine whether these cytokine differences represent significant changes in the helper function of these CD4 + T cells. We chose to examine the capacity of T cells derived from either the BALB/c or B10.D2 background to promote macrophage production of nitric oxide (NO) z, critical for the killing of many pathogens, including L. major (43, 44) . NO production is dependent on the presence of the Thl cytokine IFN-3,, and is inhibited by the Th2 cytokines IL-4 and IL-10 (45).
Strikingly, only the T cells of the B10.D2 background previously activated under neutral conditions in vitro could strongly promote NO production by macrophages, whereas T cells of the BALB/c background induced only minimal levels 1 Abbreviation used in this paper: NO, nitric oxide. of NO production (Fig. 5 ). This inability of BALB/c-derived T cells to promote NO production is not an intrinsic defect, because T cells from either BALB/c or B10.D2 mice induced to acquire the Thl phenotype by IL-12 and anti-IL-4 could induce NO production (Fig. 5) . In contrast, Th2 cells from either strain, generated by activation in the presence of IL-4, were poor inducers of NO (Fig. 5) . Thus, the differences in default Th phenotype development due to the background of the T cell (BALB/c or B10.D2) resulted in dramatic differences in the activation of a critical macrophage effector function. Fig. 3 were used to stimulate NO production from peritoneal exudate cells (FECs) as described in Materials and Methods. As controls, T cells of the Th2 or Tht phenotype were also assayed. Th2 cells were derived by addition of IL4 (100 U/ml) during the primary culture, and Thl cells were induced by the addition of 10/zg/ml 11Bll (anti-IL-4) with 5 U/ml I.b12 . The experiment shown is representative of three experiments.
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Genetic Background Effects on Th Phenotype Development
The demonstration that the genetic background of the T cell can profoundly alter the default pathway of Th phenotype development may explain certain differences between previous data from our laboratory and others. For example, we had found that T cells stimulated under neutral conditions developed into an IL-4-producing, Th0 population, which consistently showed significant effects o~anti-IL-10 and anti-IL-4 antibodies (22) . However, others, using a different TCR transgenic system maintained on the B10.A background, found little effects of anti-IL-4 and anti-IL-10 on Th phenotype development, and suggested that Thl development might represent a default pathway (23) . Our present findings may explain this discrepancy. We find that T cells from the B10 background when activated under neutral conditions develop a more Thl-like phenotype and might be expected to show quantitatively smaller effects of neutralizing IL-4 or IL-10.
Our findings taken together with previous studies on Th phenotype development and Leishmania susceptibility suggest a model for strain-dependent Th phenotype development. Early in vivo immune responses to Leishmania occur in the absence of strong macrophage activation (28), a condition that might correspond to the default pathway we observe in vitro. In the absence of strong pathogen-driven signals, strain differences in this default developmental pathway would have a large influence on the resulting Th phenotype of the immune response.
During later stages of Leishmaniasis, IL-12 expression is induced by the amastigote form of Leishmania (28, 29) . In BALB/c mice, this late IL-12 production is ineffective at driving T cell responses to a Thl phenotype since by that time T cells have acquired the Th2 (IL-4 producing) phenotype and may be resistant to the effects of IL-12. We have previously found that the effects of IL-4 on Th phenotype can dominate the effects of IL-12 for Th phenotype development (24) . Also, others have shown that Th2 cells derived from transgenic mice in vitro cannot be induced to acquire Thl specificity by IL-12 (Perez, V. C., J. Lederer, A. Lichtman, and A. K. Abbas, manuscript in preparation). In resistant mice, however, Thl-like cells generated by default during the early period of infection, would not produce su~cient amounts of IL-4 to block the effects of IL-12. In this case, amastigote-induced IL-12 could augment IFN-3' production (46, 47) and the subsequent development of a strong Thl phenotype.
The regulation of default Th phenotype development may also be important in other disease processes. For example, Scott et al. (48) have recently showed that BALB/c mice are resistant to diabetes in a transgenic model, whereas B10.D2 mice are susceptible. Also, BALB/K mice generate effective Th2-type responses to the helminth Trichuris muris, whereas B10.BR mice generate ineffective Thl responses (49) . In both of these disease models, the self antigen or pathogen may fail to generate strong cytokine signals to direct Th development, so that the default pathways of T cell development may determine disease outcome.
In vitro analysis of default Th phenotype development, however, may not always be predictive of disease outcome. For example, on the basis of in vitro Th phenotype development (Fig. 3) , DBA/2J mice would be expected to be more susceptible to L. major than BALB/c mice because the T cells develop more of a Th2-character. Rather, DBA/2J mice are less susceptible (50) . However, our observation that DBA/2J T cells develop to a more Th2-1ike phenotype than either BALB/c or B10.D2 T cells may relate to the fact that DBA/2J clear Leishmania distinctly less well than resistant mice such as B10.D2 (50) . This suggests that there are other genetic factors which determine resistance to Leishmania in addition to those affecting default Th phenotype development.
Moreover, the factors controlling susceptibility may differ between pathogens. For example, genetic susceptibility to Candida correlates well with our findings regarding in vitro Th phenotype responses. Effective immunity to Candicla is Thl dependent (51) . As our results would predict, DBA/2J mice are more susceptible to Candida than BALB/c and C57/BL6 mice (51) . Thus, the effects of genetic background on default in vitro Th phenotype development may contribute to our understanding in vivo Th subset responses to some pathogens. Since the host-pathogen relationship is complex and likely to be affected by many genes, the relative importance of default Th phenotype development in any specific in vivo situation cannot be absolutely determined.
In summary, we have demonstrated a genetic difference between T cells of the BALB/c versus B10.D2 background in their default in vitro Th phenotype development which could relate to in vivo Th responses. Genetic differences do not appear to reside within the resident splenic APC populations studied. These differences in default Th phenotype development result in significant differences in both cytokine profiles and most notably Th activity for macrophage induction of NO. Thus, this in vitro system may be useful for addressing the molecular and genetic basis for these strain differences.
